Treatment outcomes among patients with isoniazid mono-resistant tuberculosis in Mumbai, India: A retrospective cohort study
Background: Tuberculosis (TB) remains a significant cause of mortality globally, with India accounting for 27% of the estimated number of people with TB. Multidrug-resistant TB (MDR-TB) and isoniazid (INH) resistance pose additional challenges to effective treatment. We aimed to describe treatment o...
Saved in:
| Main Authors: | Sumaiya Khan, Arunima Silsarma, Raman Mahajan, Shahid Khan, Praveen Davuluri, Narendra Sutar, Aparna Iyer, Shubhangi Mankar, Vikas Oswal, Varsha Puri, Daksha Shah, Vijay Chavan, Hannah Spencer, Petros Isaakidis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Journal of Clinical Tuberculosis and Other Mycobacterial Diseases |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405579424000688 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Delayed culture conversion predicts poor outcomes for isoniazid mono-resistant TB in Uganda: a retrospective cross-sectional study from 2017– 2022
by: Joel Kabugo, et al.
Published: (2025-07-01) -
Clinical Profile and Treatment Outcome of H-mono/Polydrug-resistant Tuberculosis: A Single-center Retrospective Study
by: Shital Kabra, et al.
Published: (2024-11-01) -
Prevalence, risk factors and treatment outcomes of isoniazid resistant TB in Bulawayo city, Zimbabwe: A cohort study
by: Barbara Manyame-Murwira, et al.
Published: (2020-08-01) -
Relapse of Pulmonary Tuberculosis in Patients with Resistance to Isoniazid
by: I. A. Burmistrova, et al.
Published: (2023-07-01) -
Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment
by: Valentina Gerussi, et al.
Published: (2025-03-01)